Mirum Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.

About MIRM

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. 

CEO
Christopher Peetz
CEOChristopher Peetz
Employees
372
Employees372
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2018
Founded2018
Employees
372
Employees372

MIRM Key Statistics

Market cap
6.53B
Market cap6.53B
Price-Earnings ratio
-6.94
Price-Earnings ratio-6.94
Dividend yield
Dividend yield
Average volume
435.74K
Average volume435.74K
High today
$101.83
High today$101.83
Low today
$97.65
Low today$97.65
Open price
$98.34
Open price$98.34
Volume
360.94K
Volume360.94K
52 Week high
$130.00
52 Week high$130.00
52 Week low
$63.23
52 Week low$63.23

Stock Snapshot

Mirum Pharmaceuticals(MIRM) stock is priced at $100.57, giving the company a market capitalization of 6.53B. It carries a P/E multiple of -6.94.

As of 2026-09-08, Mirum Pharmaceuticals(MIRM) stock has fluctuated between $97.65 and $101.83. The current price stands at $100.57, placing the stock +3.0% above today's low and -1.2% off the high.

Mirum Pharmaceuticals(MIRM) shares are trading with a volume of 360.94K, against a daily average of 435.74K.

During the past year, Mirum Pharmaceuticals(MIRM) stock moved between $63.23 at its lowest and $130.00 at its peak.

During the past year, Mirum Pharmaceuticals(MIRM) stock moved between $63.23 at its lowest and $130.00 at its peak.

MIRM News

TipRanks 5h
Mirum Pharmaceuticals Announces New Chief Medical Officer Appointment

The latest announcement is out from Mirum Pharmaceuticals ( (MIRM) ). On September 8, 2026, Mirum Pharmaceuticals reported that its board had appointed Rob Mye...

TipRanks 6h
Mirum Pharmaceuticals appoints Myers as Chief Medical Officer

Mirum Pharmaceuticals (MIRM) announced the appointment of Rob Myers, M.D., as Chief Medical Officer, effective September 21, 2026. Dr. Myers will join the compa...

Investing.com 4d
Mirum Pharmaceuticals global controller sells $65,800 in stock - Investing.com

...

Mirum Pharmaceuticals global controller sells $65,800 in stock - Investing.com

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MIRM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.